(6-245) Comparing effectiveness of tirzepatide in patients with type 2 diabetes and baseline A1C <8% newly treated or switched from alternate GLP1-RA treatment
Tuesday, December 10, 2024
10:45 AM – 11:45 AM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Drug Information/Drug Use Evaluation
Co-Author(s): Michael S. Kelly, Emily M. Scopelliti
